chr11-46871557-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002334.4(LRP4):​c.4660A>G​(p.Ser1554Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.512 in 1,610,966 control chromosomes in the GnomAD database, including 218,679 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S1554N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.43 ( 15960 hom., cov: 31)
Exomes 𝑓: 0.52 ( 202719 hom. )

Consequence

LRP4
NM_002334.4 missense

Scores

1
7
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 7.42
Variant links:
Genes affected
LRP4 (HGNC:6696): (LDL receptor related protein 4) This gene encodes a member of the low-density lipoprotein receptor-related protein family. The encoded protein may be a regulator of Wnt signaling. Mutations in this gene are associated with Cenani-Lenz syndrome. [provided by RefSeq, May 2010]
LRP4-AS1 (HGNC:44128): (LRP4 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0026289523).
BP6
Variant 11-46871557-T-C is Benign according to our data. Variant chr11-46871557-T-C is described in ClinVar as [Benign]. Clinvar id is 304855.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.538 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP4NM_002334.4 linkc.4660A>G p.Ser1554Gly missense_variant Exon 31 of 38 ENST00000378623.6 NP_002325.2 O75096

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP4ENST00000378623.6 linkc.4660A>G p.Ser1554Gly missense_variant Exon 31 of 38 1 NM_002334.4 ENSP00000367888.1 O75096
LRP4ENST00000527656.1 linkn.592A>G non_coding_transcript_exon_variant Exon 3 of 3 2
LRP4-AS1ENST00000502049.3 linkn.193-1517T>C intron_variant Intron 2 of 2 2
LRP4-AS1ENST00000531719.5 linkn.292-1517T>C intron_variant Intron 3 of 3 4

Frequencies

GnomAD3 genomes
AF:
0.428
AC:
64975
AN:
151950
Hom.:
15955
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.183
Gnomad AMI
AF:
0.588
Gnomad AMR
AF:
0.462
Gnomad ASJ
AF:
0.543
Gnomad EAS
AF:
0.257
Gnomad SAS
AF:
0.528
Gnomad FIN
AF:
0.578
Gnomad MID
AF:
0.465
Gnomad NFE
AF:
0.542
Gnomad OTH
AF:
0.462
GnomAD2 exomes
AF:
0.481
AC:
118848
AN:
247302
AF XY:
0.492
show subpopulations
Gnomad AFR exome
AF:
0.171
Gnomad AMR exome
AF:
0.408
Gnomad ASJ exome
AF:
0.544
Gnomad EAS exome
AF:
0.237
Gnomad FIN exome
AF:
0.585
Gnomad NFE exome
AF:
0.547
Gnomad OTH exome
AF:
0.515
GnomAD4 exome
AF:
0.521
AC:
760306
AN:
1458896
Hom.:
202719
Cov.:
43
AF XY:
0.523
AC XY:
379363
AN XY:
725626
show subpopulations
Gnomad4 AFR exome
AF:
0.167
AC:
5603
AN:
33456
Gnomad4 AMR exome
AF:
0.420
AC:
18686
AN:
44482
Gnomad4 ASJ exome
AF:
0.540
AC:
14096
AN:
26082
Gnomad4 EAS exome
AF:
0.255
AC:
10090
AN:
39622
Gnomad4 SAS exome
AF:
0.517
AC:
44382
AN:
85820
Gnomad4 FIN exome
AF:
0.589
AC:
31390
AN:
53286
Gnomad4 NFE exome
AF:
0.543
AC:
602851
AN:
1110134
Gnomad4 Remaining exome
AF:
0.506
AC:
30495
AN:
60250
Heterozygous variant carriers
0
18901
37801
56702
75602
94503
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
16772
33544
50316
67088
83860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.427
AC:
64974
AN:
152070
Hom.:
15960
Cov.:
31
AF XY:
0.429
AC XY:
31918
AN XY:
74334
show subpopulations
Gnomad4 AFR
AF:
0.182
AC:
0.182007
AN:
0.182007
Gnomad4 AMR
AF:
0.462
AC:
0.461624
AN:
0.461624
Gnomad4 ASJ
AF:
0.543
AC:
0.543228
AN:
0.543228
Gnomad4 EAS
AF:
0.257
AC:
0.256673
AN:
0.256673
Gnomad4 SAS
AF:
0.528
AC:
0.528263
AN:
0.528263
Gnomad4 FIN
AF:
0.578
AC:
0.577513
AN:
0.577513
Gnomad4 NFE
AF:
0.542
AC:
0.542288
AN:
0.542288
Gnomad4 OTH
AF:
0.468
AC:
0.467803
AN:
0.467803
Heterozygous variant carriers
0
1697
3394
5091
6788
8485
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
606
1212
1818
2424
3030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.502
Hom.:
48042
Bravo
AF:
0.405
TwinsUK
AF:
0.553
AC:
2052
ALSPAC
AF:
0.535
AC:
2063
ESP6500AA
AF:
0.195
AC:
858
ESP6500EA
AF:
0.543
AC:
4671
ExAC
AF:
0.477
AC:
57937
Asia WGS
AF:
0.425
AC:
1481
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cenani-Lenz syndactyly syndrome Benign:2
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

not provided Benign:2
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 23321396, 21121903) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Congenital myasthenic syndrome 17 Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sclerosteosis 2 Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cenani-Lenz syndactyly syndrome;C3280402:Sclerosteosis 2;C4225377:Congenital myasthenic syndrome 17 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Uncertain
0.0
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.64
D
Eigen
Uncertain
0.36
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.66
T
MetaRNN
Benign
0.0026
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.7
L
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-2.3
N
REVEL
Uncertain
0.62
Sift
Benign
0.032
D
Sift4G
Benign
0.10
T
Polyphen
0.23
B
Vest4
0.24
MPC
0.57
ClinPred
0.043
T
GERP RS
5.8
Varity_R
0.20
gMVP
0.48
Mutation Taster
=80/20
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2306029; hg19: chr11-46893108; COSMIC: COSV66137634; API